Cargando…
Intravenous Immunoglobulin-Associated Severe Hemolytic Anemia
Intravenous immunoglobulin (IVIG) is used to treat immunodeficiency conditions, neuro-immunological, infection-related, autoimmune, and inflammatory disorders and is typically well tolerated. A hematological adverse reaction such as hemolytic anemia and neutropenia is known to occur with IVIG, which...
Autores principales: | KC, Ojbindra, Subedi, Ananta, Sharma, Rakshya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10409536/ https://www.ncbi.nlm.nih.gov/pubmed/37560548 http://dx.doi.org/10.14740/jmc4126 |
Ejemplares similares
-
A Case of Severe Hypoxia Caused by Phenazopyridine-Induced Methemoglobinemia: A near Fatal Event from Over-the-Counter Medication Use
por: KC, Ojbindra, et al.
Publicado: (2022) -
Hepatitis-associated aplastic anemia from workout supplement: Rare but potentially fatal entity
por: Bastola, Sanjog, et al.
Publicado: (2020) -
Hemolytic anemia following intravenous immunoglobulins in children with PIMS-TS: Two case reports
por: Sedlin, E., et al.
Publicado: (2023) -
Hemolytic anemia following intravenous immunoglobulin therapy in patients treated for Kawasaki disease: a report of 4 cases
por: Berard, Roberta, et al.
Publicado: (2012) -
A 2-month-old boy with hemolytic anemia and reticulocytopenia following intravenous immunoglobulin therapy for Kawasaki disease: a case report and literature review
por: Kim, Na Yeon, et al.
Publicado: (2016)